Gilead’s Antiviral Drug Remdesivir Benefits Some Hospitalized COVID-19 Patients in Clinical Trial
Preliminary findings of a clinical trial of Gilead Sciences’ (Foster City, CA, USA) remdesivir in adults hospitalized with COVID-19 support the use of the antiviral drug, although...
Latest News
- Adaptive COVID-19 Treatment Trial of New Drug Combination Enters Next Stage
- Novel Aspiration Catheter Treats Necrotizing Pancreatitis
- Novel Hydrocephalus Valve Addresses Postural Changes
- Blood Clotting Anomalies Reveal Renal Failure Risk in COVID-19
- Neuromodulation Platform Alleviates Chronic Pain
- Autonomous Drones Deliver Defibrillators in Sweden
- MIGS Device Targets Conventional Humor Outflow Barriers
- Unified Bladder Actuation System Aids Efficient Voiding